Abstract
This study explores whether an individual’s methadone dose is influenced by the level of another individual’s dose as a function of their relationship. Thirty-four subjects were recruited in this study; 16 subjects were in a partner relationship and 18 subjects were siblings. Multiple regression analysis revealed that the dose of one member of the dyad was a predictor of the dose of the other member of the dyad. Mean difference in dose was negatively associated with the correlation coefficient in sibling dyads but not partner dyads. Analysis of the dose curves showed that all partner dyads demonstrated a “collinearity pattern” or “coexistence pattern,” but a “distinct trend pattern” was only noted in sibling dyads. Our results suggest that there is a relationship between the methadone doses of members of a dyad and that this phenomenon is more remarkable in partnership dyads than sibling dyads.
Similar content being viewed by others
References
Baumeister, M., Vogel, M., Dursteler-MacFarland, K. M., Gerhard, U., Strasser, J., Walter, M., Wiesbeck, G. A., & Petitjean, S. A. (2014). Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study. Substance Abuse Treatment, Prevention, and Policy, 9, 46.
Belding, M. A., McLellan, A. T., Zanis, D. A., & Incmikoski, R. (1998). Characterizing “nonresponsive” methadone patients. Journal of Substance Abuse Treatment, 15(6), 485–492.
Caplehorn, J. R. M., Bell, J., Kleinbaum, D. G., & Gebski, V. J. (1993). Methadone dose and heroin use during maintenance treatment. Addiction, 88(1), 119–124.
Chen, I. M., Huang, C. L., Yeh, B. J., & Chien, Y. L. (2015). Health service utilization of heroin abusers: a retrospective cohort study. Addiction Behavior, 45, 281–286.
Clarke, S., Delamere, S., McCullough, L., Hopkins, S., Bergin, C., & Mulcahy, F. (2003). Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Medicine, 4(1), 33–37.
Curry, A. D., & Latkin, C. A. (2003). Gender differences in street economy and social network correlates of arrest among heroin injectors in Baltimore, Maryland. Journal of Urban Health, 80(3), 482–493.
D'Aunno, T., Pollack, H. A., Frimpong, J. A., & Wuchiett, D. (2014). Evidence-based treatment for opioid disorders: a 23-year national study of methadone dose levels. Journal of Subtance Abuse Treatment, 47(4), 245–250.
de Dios, M. A., Stanton, C. A., Caviness, C. M., Niaura, R., & Stein, M. (2013). The social support and social network characteristics of smokers in methadone maintenance treatment. American Journal of Drug and Alcohol Abuse, 39(1), 50–56.
Degenhardt, L., Charlson, F., Mathers, B., Hall, W. D., Flaxman, A. D., Johns, N., & Vos, T. (2014). The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction, 109(8), 1320–1333.
Dinis-Oliveira, R. J. (2016). Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response. Drug Metabolism Reviews, 48(4), 568–576.
Fry, C., & Dwyer, R. (2001). For love or money? An exploratory study of why injecting drug users participate in research. Addiction, 96(9), 1319–1325.
Gossop, M., Griffiths, P., Powis, B., & Strang, J. (1993). Severity of heroin dependence and HIV risk. II. Sharing injecting equipment. AIDS Care, 5(2), 159–168.
Hartel, D. M., Schoenbaum, E. E., Selwyn, P. A., Kline, J., Davenny, K., Klein, R. S., & Friedland, G. H. (1995). Heroin use during methadone-maintenance treatment—the importance of methadone dose and cocaine use. American Journal of Public Health, 85(1), 83–88.
Irwin, H. J. (1995). Codependence, narcissism, and childhood trauma. Journal of Clinical Psychology, 51(5), 658–665.
Joseph, H., Stancliff, S., & Langrod, J. (2000). Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai Journal of Medicine, 67(5–6), 347–364.
Kakko, J., Gronbladh, L., Svanborg, K. D., von Wachenfeldt, J., Ruck, C., Rawlings, B., Nilsson, L. H., & Heilig, M. (2007). A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. American Journal of Psychiatry, 164(5), 797–803.
Kelly, P. J., Ramaswamy, M., Li, X., Litwin, A. H., Berg, K. M., & Arnsten, J. H. (2012). Social networks of substance users with HIV infection: application of the Norbeck Social Support Scale. Western Journal of Nursing Research, 34(5), 621–634.
Kim, N. J., Jin, H., McFarland, W., & Raymond, H. F. (2015). Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005–2012. The International Journal on Drug Policy, 26(12), 1238–1243.
Ko, N. Y., Hsu, S. T., Chen, C. H., Lee, H. C., & Ko, W. C. (2011). Heroin dependence and bloodborne virus transmission behaviors for HIV infection among newly incarcerated injection drug users in Taiwan. Substance Use and Misuse, 46(5), 591–598.
Kreek, M. J., Borg, L., Ducat, E., & Ray, B. (2010). Pharmacotherapy in the treatment of addiction: methadone. Journal of Addict Disorders, 29(2), 200–216.
Latowsky, M. (1996). Improving detoxification outcomes from methadone maintenance treatment: the interrelationship of affective states and protracted withdrawal. Journal of Psychoactive Drugs, 28(3), 251–257.
Lin, H. C., Chen, K. Y., Wang, P. W., Yen, C. F., Wu, H. C., Yen, C. N., & Chang, H. C. (2013). Predictors for dropping-out from methadone maintenance therapy programs among heroin users in southern Taiwan. Substance Use and Misuse, 48(1–2), 181–191.
Lions, C., Carrieri, M. P., Michel, L., Mora, M., Marcellin, F., Morel, A., et al. (2014). Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial). Drug and Alcohol Dependence, 135, 1–8.
Merikangas, A. K., Segurado, R., Cormican, P., Heron, E. A., Anney, R. J., Moore, S., et al. (2014). The phenotypic manifestations of rare CNVs in schizophrenia. Schizophrenia Research, 158(1–3), 255–260.
Mouly, S., Bloch, V., Peoc'h, K., Houze, P., Labat, L., Ksouda, K., et al. (2015). Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity. British Journal of Clinical Pharmacology, 79(6), 967–977.
Neaigus, A., Friedman, S. R., Curtis, R., Jarlais, D. C. D., Furst, R. T., Jose, B., et al. (1994). The relevance of drug injectors social and risk networks for understanding and preventing HIV-infection. Social Science & Medicine, 38(1), 67–78.
Noor, S. W., Ross, M. W., Lai, D., & Risser, J. M. (2013). Clustered drug and sexual HIV risk among a sample of middle-aged injection drug users, Houston, Texas. AIDS Care, 25(7), 895–903.
Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. Lancet, 369(9566), 1047–1053.
Panaghi, L., Ahmadabadi, Z., Khosravi, N., Sadeghi, M. S., & Madanipour, A. (2016). Living with addicted men and codependency: the moderating effect of personality traits. Addiction and Health, 8(2), 98–106.
Peles, E., Schreiber, S., Hetzroni, T., Adelson, M., & Defrin, R. (2011). The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment. The Journal of Pain, 12(1), 41–50.
Pivnick, A., Jacobson, A., Eric, K., Doll, L., & Drucker, E. (1994). AIDS, HIV-infection, and illicit drug-use within inner-city families and social networks. American Journal of Public Health, 84(2), 271–274.
Preston, K. L., Umbricht, A., & Epstein, D. H. (2000). Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Archives of General Psychiatry, 57(4), 395–404.
Roux, P., Lions, C., Michel, L., Mora, M., Daulouede, J. P., Marcellin, F., … Anrs Methaville Study Group. (2014). Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions. Substance Abuse Treatment, Prevention, and Policy, 9, 37.
Simmons, J., & Singer, M. (2006). I love you… and heroin: care and collusion among drug-using couples. Substance Abuse Treatment, Prevention, and Policy, 1, 7.
Stein, M. D., Anderson, B. J., Thurmond, P., & Bailey, G. L. (2015). Comparing the life concerns of prescription opioid and heroin users. Journal of Substance Abuse Treatment, 48(1), 43–48.
Unger, J. B., Kipke, M. D., De Rosa, C. J., Hyde, J., Ritt-Olson, A., & Montgomery, S. (2006). Needle-sharing among young IV drug users and their social network members: the influence of the injection partner’s characteristics on HIV risk behavior. Addictive Behaviors, 31(9), 1607–1618.
Volavka, J., Verebey, K., Resnick, R., & Mule, S. (1978). Methadone dose, plasma level, and cross-tolerance to heroin in man. Journal of Nervous and Mental Disorders, 166(2), 104–109.
Author information
Authors and Affiliations
Contributions
Conceived and designed the experiments: WLH, YLC. Performed the experiments: YLC. Analyzed the data: WLH, YLC, CSW. Wrote the paper: WLH, YLC.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Huang, WL., Chien, YL. & Wu, CS. The Correlation between Methadone Dosages among Pairs of Heroin Users in Romantic Relationships and among Pairs of Heroin Users Who Are Siblings. Int J Ment Health Addiction 16, 1270–1282 (2018). https://doi.org/10.1007/s11469-017-9858-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11469-017-9858-4